CHRONIC PRURITUS OF UNKNOWN ORIGIN

Clinical trials for CHRONIC PRURITUS OF UNKNOWN ORIGIN explained in plain language.

Never miss a new study

Get alerted when new CHRONIC PRURITUS OF UNKNOWN ORIGIN trials appear

Sign up with your email to follow new studies for CHRONIC PRURITUS OF UNKNOWN ORIGIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New drug tested for relief of mysterious, debilitating itch

Symptom relief Recruiting now

This study is testing an injectable drug called nemolizumab to see if it can reduce severe, long-term itching that has no known cause. About 50 adults with this condition will receive either the drug or a placebo for 16 weeks. The main goal is to understand how the drug moves thr…

Matched conditions: CHRONIC PRURITUS OF UNKNOWN ORIGIN

Phase: PHASE2 • Sponsor: Galderma R&D • Aim: Symptom relief

Last updated Apr 02, 2026 14:58 UTC

CHRONIC PRURITUS OF UNKNOWN ORIGIN

Get alerted when new CHRONIC PRURITUS OF UNKNOWN ORIGIN trials appear

New drug tested for relief of mysterious, debilitating itch